{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34787877",
  "DateCompleted": {
    "Year": "2021",
    "Month": "11",
    "Day": "24"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "02",
    "Day": "04"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.26355/eurrev_202111_27117",
      "27117"
    ],
    "Journal": {
      "ISSN": "2284-0729",
      "JournalIssue": {
        "Volume": "25",
        "Issue": "21",
        "PubDate": {
          "Year": "2021",
          "Month": "Nov"
        }
      },
      "Title": "European review for medical and pharmacological sciences",
      "ISOAbbreviation": "Eur Rev Med Pharmacol Sci"
    },
    "ArticleTitle": "COVID-19 vaccines and vaccination program for aging adults.",
    "Pagination": {
      "StartPage": "6719",
      "EndPage": "6730",
      "MedlinePgn": "6719-6730"
    },
    "Abstract": {
      "AbstractText": [
        "COVID-19 vaccines have developed quickly, and vaccination programs have started in most countries to fight the pandemic. The aging population is vulnerable to different diseases, also including the COVID-19. A high death rate of COVID-19 was noted from the vulnerable aging population. A present scenario regarding COVID-19 vaccines and vaccination program foraging adults had been discussed.",
        "This paper reviews the current status and future projections till 2050 of the aging population worldwide. It also discusses the immunosenescence and inflammaging issues facing elderly adults and how it affects the vaccinations such as influenza, pneumococcal, and herpes zoster.",
        "This paper recommends clinical trials for all approved COVID-19 vaccines targeting the elderly adult population and to project a plan to develop a next-generation COVID-19 vaccine.",
        "The review has mapped the COVID-19 vaccination status from the developed and developing countries for the elderly population. Finally, strategies to vaccinate all elderly adults globally against COVID-19 to enhance longevity has been suggested."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Barasat, Kolkata, West Bengal, India. drchiranjib@yahoo.com."
          }
        ],
        "LastName": "Chakraborty",
        "ForeName": "C",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Sharma",
        "ForeName": "A R",
        "Initials": "AR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bhattacharya",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Agoramoorthy",
        "ForeName": "G",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lee",
        "ForeName": "S-S",
        "Initials": "SS"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Italy",
    "MedlineTA": "Eur Rev Med Pharmacol Sci",
    "NlmUniqueID": "9717360",
    "ISSNLinking": "1128-3602"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Eur Rev Med Pharmacol Sci. 2022 Jan;26(1):4-5",
      "PMID": "35049035"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Aging"
    },
    {
      "QualifierName": [
        "immunology",
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "immunology"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunization Programs"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunosenescence"
    },
    {
      "QualifierName": [
        "immunology",
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    }
  ]
}